Clinical Practice Update: Management of Infectious Endophthalmitis After Intravitreal Anti-VEGF Injection.
J Vitreoretin Dis
; 6(6): 443-451, 2022.
Article
em En
| MEDLINE
| ID: mdl-37009541
ABSTRACT
Although infectious endophthalmitis after intravitreal antivascular endothelial growth factor injections is rare, it is the most feared and potentially devastating complication of this procedure. There is no high-level evidence to provide definitive guidance on the management of endophthalmitis occurring after intravitreal injection (IVI). This clinical practice update reviews the published literature regarding post-IVI endophthalmitis and highlights areas in which further research is needed to better guide its management.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article